Advertisement
ExclusiveHong Kong stock exchange’s ‘double-dip’ IPO reform gets few takers as investors shy away from listings
- In the first quarter, only Beijing Health Guard Biotechnology filed to use the rule change, among 65 companies that sought listings
- Lack of interest has more to do with lacklustre IPO activity than the reform per se, which will draw interest when listings pick up, analysts say
3-MIN READ3-MIN
1

A recent Hong Kong Exchanges and Clearing (HKEX) measure that allows investors to “double dip”, implemented as part of an attempt to revive the city’s sluggish initial public offering (IPO) market, has received a negligible response.
Under the rule, existing shareholders and cornerstone investors of a new IPO applicant can subscribe for additional shares, or double dip, under certain conditions. The HKEX introduced the reform in November, around the same time it launched other measures, such as a digital IPO platform, to breathe life into the moribund primary market.
The move aims to encourage more companies to involve large-ticket or well-known investors, who are usually brought into the IPO process before the formal book-building process starts, to ensure a successful listing.
Advertisement
However, amid sluggish IPO activity, the take-up rate has been minimal so far.

In the first quarter of 2024, only one company, Beijing Health Guard Biotechnology, filed a waiver to use the rule change among 65 companies that sought listings on the mainboard, according to the Post’s research.
Advertisement
Advertisement
Select Voice
Select Speed
1.00x